Sanara MedTech Inc.

NASDAQ:SMTI

Medical - Instruments & Supplies

Healthcare
$32.73 +3.44%

+$0.73 today

Market cap
$300.55M
Beta
1.19
P/E (TTM)
-5.7
EPS (TTM)
-$3.86
52W Low $16.05High $35.95

Volume 0.07M

Average 0.06M

SMTI Free Cash Flow

Operating cash flow minus capital expenditures: cash available for debt repayment, dividends, and buybacks.

Sanara MedTech Inc.NASDAQ: SMTI

Free Cash Flow · Q1 FY2026 · quarter ended Mar 2026

Free cash flow dips below year-ago levels

Q1 FY2026 free cash flow of $2.51M (cash outflow) fell 32.6% year over year, behind the +245.8% change in trailing-twelve-month free cash flow.

Context

  • Free cash flow amounted to 2.1% of revenue in FY2025, up 1.8 pp from a year earlier.
  • Free cash flow increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -32.6% toward the trailing-twelve-month pace of +245.8%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$2.51M-165.0% QoQ
Last fiscal yearDec 2025
$2.16M+953.9% YoY
LTMMar 2026
$3.37M+245.8% YoY
Free Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-32.6%——
1 year+953.9%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Free Cash Flow history

USD · from the cash flow

Latest · FY2025
2.16M USD
Year-over-year change
+953.9%

Free Cash Flow vs competitors

How SMTI compares with its peers on the latest reported figures

  • Peers report in different currencies, so free cash flow is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +245.8% is the 3rd highest of 10, against a peer median of +94.9%.
  • Free cash flow amounts to 3.1% of revenue for SMTI, versus a peer median of 12.1%.
SMTI Competitors
Free Cash Flow for SMTI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TRDAEntrada Therapeutics, Inc.LTM Mar 2026$131.64M USD+126.9%+10.3%2294.2%
TBRGTruBridge, Inc.LTM Mar 2026$41.97M USD+95.1%+39.9%12.1%
VMDViemed Healthcare, Inc.LTM Mar 2026$25.92M USD+500.0%+35.0%9.0%
SGHTSight Sciences, Inc.LTM Mar 2026$25.4M USD+3.9%-27.0%31.9%
STXSStereotaxis, Inc.LTM Mar 2026$15.52M USD+94.9%+8.5%49.8%
HITIHigh Tide Inc.LTM Apr 2026CA$15.08M CAD+7.5%—2.2%
LFMDLifeMD, Inc.LTM Mar 2026$14.83M USD+368.4%-67.4%6.8%
XGNExagen Inc.LTM Mar 2026$14.13M USD-8.6%-26.9%20.7%
NEONeoGenomics, Inc.LTM Jun 2026$7.36M USD-61.6%-39.2%1.0%
SMTISanara MedTech Inc.LTM Mar 2026$3.37M USD+245.8%—3.1%
Peer median (excluding SMTI) —+94.9%-9.2%12.1%

Competitors are the stored peer set for SMTI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(7.99M)(8.09M)(4.44M)(9.91M)(27.66M)
Depreciation & Amortization596.98K2.37M3.68M4.92M28.56M
Deferred Income Tax0(5.84M)000
Stock-Based Compensation2.67M2.7M3.44M4.44M718.71K
Change in Working Capital(1.18M)517.62K(3.28M)(911.72K)(3.84M)
Accounts Receivables(774.81K)(2.27M)(1.73M)(4.54M)4.03M
Inventory(1.15M)(517.27K)(1.55M)1.44M(431.33K)
Accounts Payables99.13K(423.75K)575.15K(471.21K)1.24M
Other Working Capital645.56K3.73M(577.32K)2.66M(8.68M)
Other Non-Cash Items1.1M2.79M(2.64M)1.44M9.02M
Operating Cash Flow(4.81M)(5.55M)(3.25M)(23.78K)6.79M
Capital Expenditures(750.45K)(747.02K)(265.25K)(229.3K)(4.63M)
Acquisitions (Net)0(2.52M)(9.94M)00
Purchases of Investments(4.53M)(250K)0(5.3M)9.48M
Sales of Investments0000(2.96M)
Other Investing Activities(578.59K)(598.45K)650(1.1M)(10.47M)
Investing Cash Flow(5.28M)(3.51M)(10.21M)(6.61M)(8.36M)
Debt Repayment009.69M19.59M0
Common Stock Issued28.94M0911.37K00
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(642.53K)(627.35K)(958.59K)(2.15M)(8.48M)
Financing Cash Flow28.3M(627.35K)9.64M17.37M(8.48M)
Effect of Forex Changes00000
Net Change in Cash18.2M(9.69M)(3.81M)10.73M(10.03M)
Free Cash Flow(5.56M)(6.3M)(3.51M)(253.08K)2.16M

Sanara MedTech Inc.

NASDAQ:SMTI

Intrinsic Alpha fair value

Locked

Current Price

$32.73

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.